{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:32:53Z","timestamp":1782444773806,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Tama City Medical Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39383-w","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:14:58Z","timestamp":1770556498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["One-year body weight loss and gain as independent predictors of frailty-related outcomes and mortality in an aging Japanese population"],"prefix":"10.1038","volume":"16","author":[{"given":"Hitomi","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sasabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"39383_CR1","doi-asserted-by":"publisher","first-page":"623","DOI":"10.14740\/jocmr3917","volume":"11","author":"H Fujii","year":"2019","unstructured":"Fujii, H. et al. Yubi-wakka (finger-ring) test: A tool to detect prefrailty in elderly populations, a pilot study. J. Clin. Med. Res. 11, 623\u2013628 (2019).","journal-title":"J. Clin. Med. Res."},{"key":"39383_CR2","doi-asserted-by":"publisher","first-page":"e061613","DOI":"10.1136\/bmjopen-2022-061613","volume":"12","author":"H Fujii","year":"2022","unstructured":"Fujii, H. et al. Sarcopenia and coexistent risk factors detected using the Yubi-wakka (finger-ring) test in adults aged over 65 years in the public annual health checkup in Tama City, tokyo: a cross-sectional study. BMJ Open. 12, e061613 (2022).","journal-title":"BMJ Open."},{"key":"39383_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.14740\/jocmr4827","volume":"15","author":"H Fujii","year":"2023","unstructured":"Fujii, H. et al. Factors influencing sarcopenic changes in YUBI-WAKKA finger-ring test results after one year: A retrospective observational study. J. Clin. Med. Res. 15, 23\u201330 (2023).","journal-title":"J. Clin. Med. Res."},{"key":"39383_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1253\/circj.CJ-18-1038","volume":"83","author":"E Kodani","year":"2019","unstructured":"Kodani, E. et al. Prevalence and incidence of atrial fibrillation in the general population based on National health insurance special health checkups TAMA MED Project-AF. Circ. J. 83, 524\u2013531 (2019).","journal-title":"Circ. J."},{"key":"39383_CR5","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1253\/circj.CJ-20-0329","volume":"84","author":"E Kodani","year":"2020","unstructured":"Kodani, E. et al. Impact of chronic kidney disease classification on new-onset atrial fibrillation in the general population: the TAMA MED Project-AF and CKD. Circ. J. 84, 1693\u20131700 (2020). (Corrigendum Circ. J. 84, 2325 [2020]).","journal-title":"Circ. J."},{"key":"39383_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.14740\/jocmr4085","volume":"12","author":"T Kaneko","year":"2020","unstructured":"Kaneko, T. et al. Medical and dental visits of chronic kidney disease-diagnosed participants analyzed from the specific health checkups results in japan: TAMA MED Project-CKD. J. Clin. Med. Res. 12, 115\u2013121 (2020).","journal-title":"J. Clin. Med. Res."},{"key":"39383_CR7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ckj\/sfab014","volume":"14","author":"T Kaneko","year":"2021","unstructured":"Kaneko, T. et al. Anemia and atrial fibrillation as independent risk factors for new-onset chronic kidney disease: the TAMA-MED Project-CKD and AF. Clin. Kidney J. 14, 2221\u20132226 (2021).","journal-title":"Clin. Kidney J."},{"key":"39383_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s10157-024-02507-5","volume":"28","author":"T Kaneko","year":"2024","unstructured":"Kaneko, T. et al. High body mass index and triglyceride levels at health checkups increase the risk of new-onset chronic kidney disease and worsening renal function: the TAMA MED Project-CKD. Clin. Exp. Nephrol. 28, 1016\u20131026 (2024).","journal-title":"Clin. Exp. Nephrol."},{"key":"39383_CR9","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. Biol. Sci. Med. Sci. 56, M146\u2013M156 (2001).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"39383_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.14283\/jfa.2019.44","volume":"9","author":"RS Crow","year":"2020","unstructured":"Crow, R. S. et.al. Reported weight change in older adults and presence of frailty. J. Frailty Aging. 9, 74\u201381 (2020).","journal-title":"J. Frailty Aging"},{"key":"39383_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/ggi.12209","volume":"14","author":"M Yamada","year":"2014","unstructured":"Yamada, M., Moriguch, Y., Mitani, T., Aoyama, T. & Arai, H. Age-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age. Geriatr. Gerontol. Int. 14, 8\u201314 (2014).","journal-title":"Geriatr. Gerontol. Int."},{"key":"39383_CR12","doi-asserted-by":"crossref","unstructured":"Wei, S., Nguyen, T. T., Zhang, Y., Ryu, D. & Gariani, K. Sarcopenic obesity: Epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol 14, 1-11 (2023).","DOI":"10.3389\/fendo.2023.1185221"},{"key":"39383_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/jdi.14274","volume":"15","author":"M Sato","year":"2024","unstructured":"Sato, M. et al. Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study. J. Diabetes Investig. 15, 1510\u20131518 (2024).","journal-title":"J. Diabetes Investig"},{"key":"39383_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/ggi.12851","volume":"17","author":"K Yamazaki","year":"2017","unstructured":"Yamazaki, K. et al. Is there an obesity paradox in the Japanese elderly population? A community-based cohort study of 13,280 men and women. Geriatr. Gerontol. Int. 17, 1257\u20131264 (2017).","journal-title":"Geriatr. Gerontol. Int."},{"key":"39383_CR15","doi-asserted-by":"publisher","first-page":"e1001998","DOI":"10.1371\/journal.pmed.1001998","volume":"13","author":"EM Bucholz","year":"2016","unstructured":"Bucholz, E. M. et al. Underweight, markers of cachexia, and mortality in acute myocardial infarction: a prospective cohort study of elderly medicare beneficiaries. PLoS Med. 13, e1001998. 10.1371 (2016).","journal-title":"PLoS Med."},{"key":"39383_CR16","doi-asserted-by":"publisher","first-page":"E621","DOI":"10.1152\/ajpendo.00277.2023","volume":"325","author":"SN Heyman","year":"2023","unstructured":"Heyman, S. N., Armaly, Z., Hamo-Giladi, D. B. & Abassi, Z. Novel perspectives regarding the physiologic mechanisms by which Gliflozins induce reticulocytosis and erythrocytosis. Am. J. Physiol. Endocrinol. Metab. 325, E621\u2013E623 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"39383_CR17","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/clc.23508","volume":"43","author":"ME Johansen","year":"2020","unstructured":"Johansen, M. E. & Argyropoulos, C. The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use sodium glucose cotransporter 2 inhibitors is now. Clin. Cardiol. 43, 1376\u20131387 (2020).","journal-title":"Clin. Cardiol."},{"key":"39383_CR18","doi-asserted-by":"publisher","first-page":"e00651","DOI":"10.1002\/prp2.651","volume":"8","author":"M Ben-Eltriki","year":"2020","unstructured":"Ben-Eltriki, M. et al. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence. Pharmacol. Res. Perspect. 8, e00651 (2020).","journal-title":"Pharmacol. Res. Perspect."},{"key":"39383_CR19","unstructured":"Yibirin, M. et al. Adverse effects associated with proton pump inhibitor use. Cureus 13, e12759 .DOI 10.7759\/cureus.12759"},{"key":"39383_CR20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cger.2022.05.011","volume":"38","author":"M McConnell","year":"2022","unstructured":"McConnell, M. & Shieh, A. Polypharmacy in osteoporosis treatment. Clin. Geriatr. Med. 38, 715\u2013726 (2022).","journal-title":"Clin. Geriatr. Med."},{"key":"39383_CR21","doi-asserted-by":"crossref","unstructured":"Falkenstein, M., Karthaus, M. & Br\u00fcne-Cohrs, U. Age-related diseases and driving safety. Geriatrics. 5, 80 (2020). (2020).","DOI":"10.3390\/geriatrics5040080"},{"key":"39383_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan, F. & Wehling, M. Polypharmacy in older adults: A narrative review of definitions, epidemiology and consequences. Eur. Geriatr. Med. 12, 443\u2013452 (2021).","journal-title":"Eur. Geriatr. Med."},{"key":"39383_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2165\/11592000-000000000-00000","volume":"28","author":"K Richardson","year":"2011","unstructured":"Richardson, K., Ananou, A., Lafortune, L., Brayne, C. & Matthews, F. E. Variation over time in the association between polypharmacy and mortality in the older population. Drugs Aging. 28, 547\u2013560 (2011).","journal-title":"Drugs Aging"},{"key":"39383_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5551\/jat.64368","volume":"31","author":"R Sato","year":"2024","unstructured":"Sato, R. et al. Impact of low-density lipoprotein cholesterol levels at acute coronary syndrome admission on long-term clinical outcomes. J. Atheroscler Thromb. 31, 444\u2013460 (2024).","journal-title":"J. Atheroscler Thromb."},{"key":"39383_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/gerona\/glq082","volume":"65","author":"DG Le Couteur","year":"2010","unstructured":"Le Couteur, D. G. et al. The association of Alanine transaminase with aging, frailty, and mortality. J. Gerontol. Biol. Sci. Med. Sci. 65, 712\u2013717 (2010).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"39383_CR26","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/gerona\/glx126","volume":"73","author":"U Vespasiani-Gentilucci","year":"2018","unstructured":"Vespasiani-Gentilucci, U. et al. Low Alanine aminotransferase levels in the elderly population: Frailty, disability, sarcopenia, and reduced survival. J. Gerontol. Biol. Sci. Med. Sci. 73, 925\u2013930 (2018).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39383-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:53:45Z","timestamp":1772193225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39383-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39383"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39383-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Due to the retrospective nature of the study, Institutional Review Board of Tama Center Mirai Clinic (no. 2024014) waived the need of obtaining informed consent.\u00a0Tama City included information on the application form for the checkup explaining that participants\u2019 anonymized data may be analyzed and published for public health research and that they have the right to opt out or refuse their consent. The same information was provided on the TAMA CITY Medical Association website.\u00a0Our study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). We obtained Institutional Review Board approval from the Tama Center Mirai Clinic (no. 2024014).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"7778"}}